Skip to main content
Lifecare ASA logo

Lifecare ASA — Investor Relations & Filings

Ticker · LIFE ISIN · NO0013355859 LEI · 254900D88MYGZ7JD5P39 OL Manufacturing
Open in API
Filings indexed 812 across all filing types
Latest filing 2024-10-02 Earnings Release
Country NO Norway
Listing OL LIFE

About Lifecare ASA

https://lifecare.no/

Lifecare ASA is a clinical-stage medical sensor company specializing in the development of nanotechnology for medical applications. Its core activity involves creating miniaturized, implantable, and long-term nanobiosensors for the continuous monitoring of various body analytes. The company's primary focus is on developing a sensor for correct and continuous glucose monitoring to improve diabetes management. The business model is based on developing and licensing its proprietary sensor technology to facilitate the production and sale of advanced medical devices.

Recent filings

Filing Released Lang Actions
Lifecare ASA First successful production based on automatization of critical processes
Earnings Release Classification · 1% confidence The document is a press release dated October 2, 2024, announcing a significant operational milestone: the successful completion of production based on automated processes for their glucose sensor, Sencell. It details the technical steps involved and the next phase (repeating the process in Mainz and continuing improvements towards scalable production). This type of announcement, focusing on operational progress, technology validation, and future plans, is characteristic of an Earnings Release (ER) or a general operational update. Since it is not a full quarterly report (IR) or a formal transcript (CT), and it focuses on key operational achievements rather than just financial figures, ER is the most appropriate fit among the provided options for a significant, timely operational update. It is not a formal regulatory filing like a 10-K or a specific notice like DIV or DIRS. Given the content is an announcement of a major operational success, ER (Earnings Release, often used broadly for key operational/financial updates) is selected, although it could also be considered RNS if ER is strictly limited to financial figures only. However, operational breakthroughs are frequently bundled with ERs or treated as significant news releases. Q2 2024
2024-10-02 English
Lifecare ASA First successful production based on automatization of critical processes
Regulatory Filings Classification · 1% confidence The document is a short press release dated October 2, 2024, announcing a specific operational achievement: the successful production of their glucose sensor (Sencell) using automated processes. It is not a full financial report (like 10-K or IR), nor is it a transcript (CT) or a formal dividend/share change notice. It is an announcement of a business/operational update. Since it is a general operational announcement that doesn't fit the specific categories like ER (Earnings Release), CAP (Financing), or DIV (Dividend), it falls best under the general regulatory announcement category, RNS, which serves as a fallback for miscellaneous regulatory news releases.
2024-10-02 English
OSLO BØRS – TRADING SUSPENSION WARRANTS
Regulatory Filings Classification · 1% confidence The document text is extremely short (262 characters) and announces a specific regulatory action taken by the Oslo Børs (stock exchange) based on a prior announcement from Lifecare ASA. The content is a direct, brief notification about a trading suspension for warrants. This type of immediate, non-standardized regulatory update that doesn't fit the specific categories (like 10-K, ER, DIV, etc.) is best classified under the general regulatory announcement fallback category.
2024-10-01 English
Lifecare ASA: Ex. consolidation (reverse split) of shares and warrants today
Share Issue/Capital Change Classification · 1% confidence The document explicitly announces a 'Consolidation (reverse split) of shares and Warrants' with an 'Ex. date: 1 October 2024'. This action directly relates to a change in the company's capital structure (shares). Reviewing the definitions, 'Share Issue/Capital Change (Code: SHA)' is defined as 'Announcement regarding new share issues, stock splits, or other capital changes.' Since a reverse split is a capital change/stock split, SHA is the most appropriate classification. The document is short and serves as an announcement of this corporate action.
2024-10-01 English
Lifecare ASA: Ex. consolidation (reverse split) of shares and warrants today
Share Issue/Capital Change Classification · 1% confidence The document explicitly announces a 'Consolidation (reverse split) of shares and Warrants' for Lifecare ASA, effective on the 'Ex. date: 1 October 2024'. This action directly relates to a change in the company's capital structure (shares outstanding). Based on the definitions, 'Share Issue/Capital Change (Code: SHA)' covers announcements regarding new share issues, stock splits, or other capital changes. A reverse split falls squarely under this category. The document is short and serves as an official announcement, not the full report itself.
2024-10-01 English
Lifecare ASA: Share consolidation (reverse split) and change of par value
Share Issue/Capital Change Classification · 1% confidence The document explicitly announces a 'SHARE CONSOLIDATION (REVERSE SPLIT)' following a resolution from an extraordinary general meeting. This action directly impacts the company's share structure and capital. Reviewing the definitions, 'Share Issue/Capital Change (SHA)' is the most appropriate category, as a reverse split is a change in the capital structure involving the number of shares outstanding. The document is a direct announcement of this corporate action, not a general regulatory filing (RNS) or a report announcement (RPA).
2024-09-30 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.